Publication date: December 2026 Source: Gynecologic Oncology, Volume 215 Author(s): Kwong-Kwok Wong, Wei Deng, Yvonne T.M. Tsang, S. John Weroha, Hye Sook Chon, Vivek Podder, Floor Backes, Eric Thomas, Meaghan Elizabeth Tenney, Shannon N. Westin, Merry J. Markham, Robert L. Coleman, Thomas J. Herzog, David M. Gershenson, Brian M. Slomovitz
Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study. // Gynecologic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S009082582602192X?dgcid=rss_sd_all
Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study. Gynecologic Oncology. https://www.sciencedirect.com/science/article/pii/S009082582602192X?dgcid=rss_sd_all
“Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study.” Gynecologic Oncology.
@article{article47176,
title = {Exploratory biomarker analysis of ribociclib plus letrozole in recurrent low-grade serous carcinoma: A GOG-3026 correlative study},
journal = {Gynecologic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S009082582602192X?dgcid=rss_sd_all}
}